Insulin Knockout Mice Have Extended Survival but Volatile Blood Glucose Levels on Leptin Therapy

Area of Science:

• Endocrinology
• Metabolic research
• Diabetes research

Background:

• Leptin's role in diabetes treatment is investigated, but its insulin-independent actions remain unclear.
• Previous models of type 1 diabetes did not fully eliminate insulin, complicating the assessment of leptin's effects.
• Understanding leptin's insulin-independent functions is crucial for developing novel diabetes therapies.

Purpose of the Study:

• To determine the extent to which leptin can normalize metabolic parameters without insulin.
• To assess the viability and metabolic stability of animals lacking insulin but treated with leptin.

Main Methods:

• Maximized insulin action blockage using an insulin receptor antagonist in streptozotocin-diabetic mice.
• Administered leptin to adult insulin knockout (InsKO) mice, assessing survival and metabolic profiles.
• Monitored blood glucose, plasma hormones, lipids, and ketone bodies.

Main Results:

• Leptin reduced blood glucose even with maximal insulin receptor blockade.
• Leptin-treated InsKO mice survived for up to three weeks without insulin therapy.
• Leptin normalized corticosterone, glucagon, ketone bodies, lipids, and fatty acids.
• However, leptin-treated InsKO mice showed significant fed hyperglycemia and fasting hypoglycemia.

Conclusions:

• Leptin demonstrates significant insulin-independent metabolic benefits in type 1 diabetes models.
• Complete insulin absence results in volatile glucose control and finite survival, despite leptin's positive effects.
• Leptin's therapeutic potential in diabetes requires careful consideration of its interaction with insulin signaling.